[关键词]
[摘要]
目的:探讨Ex-press微型引流器植入联合深层巩膜切除术治疗难治性青光眼的临床疗效。
方法:收集2014-01/11难治性青光眼患者24例30眼,施行Ex-press微型引流器(P-50)植入联合深层巩膜切除术。术后随访12mo,分析术前及术后疼痛感、眼压、视力、并发症等情况。
结果:术后随访期间所有患者眼痛症状均缓解。术前平均眼压为51.15±2.60mmHg,末次随访时平均眼压15.11±2.51mmHg,术后眼压与术前相比,差异有统计学意义(P<0.05)。术后视力有提高者8眼,无显著改变者22眼。术后前房出血2眼(7%),1wk后出血吸收。
结论:Ex-press微型引流器植入联合深层巩膜切除术是治疗难治性青光眼相对安全、有效的方法,能显著降低眼压,减少患者痛苦,且并发症少。
[Key word]
[Abstract]
AIM: To evaluate the effect for refractory glaucoma by using Ex-Press miniature implantation with deep sclerectomy.
METHODS: Thirty eyes in 24 patients with refractory glaucoma were treated by Ex-Press miniature(P50)implantation with deep sclerectomy. The patients' symptom, intraocular pressure(IOP), visual acuity and complications were analyzed in a 12mo follow-up period.
RESULTS: During the follow-up period, all patients' ocular pain was reduced. The mean IOP before operation and at the last follow-up time were 51.15±2.60mmHg(1kPa=7.5mmHg)and 15.11±2.51mmHg, respectively, there was significant difference(P<0.05). Postoperative visual acuity was improved in 8 eyes,had no significant change in 22 eyes. After operation, hyphema of anterior chamber appeared in 2 eye(7%), which were obsorbed after 1wk.
CONCLUSION: Ex-Press miniature implantation combined with deep sclerectomy surgery is a relatively effective and safe treatment for the patients with refractory glaucoma. This method can significantly degrade the IOP, lessen ocular pain and reduce the complications risk.
[中图分类号]
[基金项目]
国家自然科学基金资助项目(No.81371045); 沈阳市科技计划项目基金资助项目(No.F13-220-9-37)